Synapse - Mary Helen Larsen

Mary Helen Larsen

Research Focus

Nursing; Clinical Trials Nurse II

Recent additions – View all

Phase II trial of Pembrolizumab and OLApaRib (POLAR) maintenance for select patients (pts) with metastatic pancreatic cancer (mPC) with (A) homologous recombination deficiency (HRD), (B) non-core HRD (ncHRD) and (C) exceptional response to platinum
Meeting Abstract

Park, W.; O'Connor, C.; Chou, J.; Schwartz, C.; Larsen, M.; Varghese, A.; Yu, K.; Balogun, F.; Yang, J.; Katz, S.; more...
Annals of Oncology (2024)

Fulltext@MSK | Save
BNT321, a novel monoclonal antibody targeting sialyl Lewis A: Phase 1 monotherapy and combination with mFOLFIRINOX in patients with advanced CA19-9 expressing cancers
Meeting Abstract

O'Reilly, E. M.; Bauer, T. M.; Borazanci, E. H.; Pelster, M.; Varghese, A. M.; Park, W.; Patel, M. R.; Jameson, G. S.; Larsen, M.; Chin, K.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Co-authors at MSK

2

O'Reilly
2

Park
2

Varghese
1

Balacha...
1

Balogun
1

Bandlamudi
1

Berger
1

Capanu
1

Chin
1

Chou
1

Iacobuz...
1

Kelsen
1

O'Connor
1

Pe'er
1

Riaz
1

Schwartz
1

Umeda
1

Yang
1

Yu

Types of Work

Publications

Annals of Oncology (1)
Journal of Clinical Oncology (1)